For: | Leman JK, Sandford SK, Rhodes JL, Kemp RA. Multiparametric analysis of colorectal cancer immune responses. World J Gastroenterol 2018; 24(27): 2995-3005 [PMID: 30038466 DOI: 10.3748/wjg.v24.i27.2995] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i27/2995.htm |
Number | Citing Articles |
1 |
Sandra Meršaková, Zora Lasabová, Ján Strnádel, Michal Kalman, Eva Gabonova, Peter Sabaka, Rachele Ciccocioppo, Luis Rodrigo, Peter Kruzliak, Peter Mikolajčík. Genomic profile and immune contexture in colorectal cancer—relevance for prognosis and immunotherapy. Clinical and Experimental Medicine 2021; 21(2): 195 doi: 10.1007/s10238-020-00649-w
|
2 |
Shuting Wen, Long He, Zhuotai Zhong, Hong Mi, Fengbin Liu. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.604252
|
3 |
Maria Abancens, Viviana Bustos, Harry Harvey, Jean McBryan, Brian J. Harvey. Sexual Dimorphism in Colon Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.607909
|
4 |
Aparajita Budithi, Sumeyye Su, Arkadz Kirshtein, Leili Shahriyari. Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer. Cancers 2021; 13(11): 2632 doi: 10.3390/cancers13112632
|
5 |
Ke Zhang, Xiao Xie, Shuang-Lin Zheng, Yuan-Run Deng, Dan Liao, Hai-Chen Yan, Xi Kang, Hui-Ping Jiang, Sui-Qun Guo. Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1276907
|
6 |
Varun Sasidharan Nair, Reem Saleh, Salman M. Toor, Nehad M. Alajez, Eyad Elkord. Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01530
|
7 |
Zhuangzhuang Zheng, Chenbin Bian, Huanhuan Wang, Jing Su, Lingbin Meng, Ying Xin, Xin Jiang. Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221138383
|
8 |
Eva Andreuzzi, Alessandra Capuano, Evelina Poletto, Eliana Pivetta, Albina Fejza, Andrea Favero, Roberto Doliana, Renato Cannizzaro, Paola Spessotto, Maurizio Mongiat. Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis. International Journal of Molecular Sciences 2020; 21(10): 3686 doi: 10.3390/ijms21103686
|
9 |
Arkadz Kirshtein, Shaya Akbarinejad, Wenrui Hao, Trang Le, Sumeyye Su, Rachel A. Aronow, Leili Shahriyari. Data Driven Mathematical Model of Colon Cancer Progression. Journal of Clinical Medicine 2020; 9(12): 3947 doi: 10.3390/jcm9123947
|
10 |
Zeyu Wang, Hongjing Pan, Jun Zhou, Dong Wan. CBLN2 overexpression inhibits colorectal cancer progression and improves immunotherapy responses. International Immunopharmacology 2025; 144: 113566 doi: 10.1016/j.intimp.2024.113566
|
11 |
J. K. H. Leman, L. Munoz-Erazo, R. A. Kemp. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1226: 1 doi: 10.1007/978-3-030-36214-0_1
|
12 |
Samaa Abdullah. Recent Understanding of Colorectal Cancer Treatment. 2022; doi: 10.5772/intechopen.105982
|
13 |
Xingru Li, Pär Larsson, Ingrid Ljuslinder, Daniel Öhlund, Robin Myte, Anna Löfgren-Burström, Carl Zingmark, Agnes Ling, Sofia Edin, Richard Palmqvist. Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells. Cancers 2020; 12(4): 923 doi: 10.3390/cancers12040923
|
14 |
Luis Munoz-Erazo, Janet L. Rhodes, Valentine C. Marion, Roslyn A. Kemp. Tertiary lymphoid structures in cancer – considerations for patient prognosis. Cellular & Molecular Immunology 2020; 17(6): 570 doi: 10.1038/s41423-020-0457-0
|